Leukocyte-associated immunoglobulin-like receptor-1 overexpression decreased Glut1 and epithelial-mesenchymal transition-related molecules, thereby inhibiting osteosarcoma cell metabolism and metastasis and providing a new target for slowing osteosarcoma progression (106). Here, SLC2A1 is linked to osteosarcoma.